Habilitat Hawaii Slam Poetry Night 2011


 

Habilitat Hawaii Slam Poetry Night 2011 – Connie DeDonna teaches poetry at HabilitatHawaii Slam Poetry Night 2011 Cornelia “Connie D.” DeDona www.blogger.com Cornelia is the award winning author of four books and a co-editor, and creator of one Anthology to which she has contributed her poetry and art. She is a ranked Script Writer on Fan Story. She tied for second place in September 2009 in the IBPC with her poem Toad Festival. Published since 2008 in Rain Bird; an annual Art and Literary journal of Windward Community College, Kaneohe, Hawaii, Cornelia received Rain Bird’s, Kolekolea Honorable Mention in 2010 for her poem, Writing Retreat. In 2011, two of her art photos were also accepted for publication. Her recent book “Letters to a Prisoner” by Connie D. won an Honorable Mention in Poetry at the 2011 New York Book Festival in June. Her poems and short stories are published in several print and online journals, including, The Dark Side and Clean Sweep in One Forty Fiction, and also The Great Pacific Garbage Patch in The Hawaii Fishing News, June 2011. She facilitates a monthly creative writing class for Habilitat Hawaii, Long Term Substance Abuse Treatment program in Kaneohe Hawaii. She is a member of the National League of American Pen Women and the Friends of the Library in Honolulu, where she also volunteers. She is also a sustaining member of the Academy of American Poets. Habilitat Hawaii is the final solution to substance abuse offering long term substance abuse treatment to people from around the globe

 

Drug showed promise in clearing drug-resistant tuberculosis

Filed under: drug treatment news 2011

Many patients fail to complete their treatment, a factor which has fueled a rise in the drug-resistant forms. Although rare, 77 countries worldwide reported at least one case of XDR-TB by the end of 2011, according to the World Health Organization. In …
Read more on Reuters AlertNet

 

GSK, XenoPort terminate extended-release gabapentin deal

Filed under: drug treatment news 2011

GSK had commercialization and development rights in the U.S., where the drug was approved for the treatment of restless legs syndrome in April 2011, and for post-shingles pain in June 2012. All of these rights are being returned to XenoPort. XenoPort …
Read more on FierceDrugDelivery